FDA approval for Portola’s Andexxa

After denying Portola’s Andexxa 19 months ago, the FDA as approved the company’s drug that It is the first and only antidote for life-threatening or uncontrolled bleeding in patients taking blood thinners made with rivaroxaban and apixaban.

Portola will launch Andexxa next month, although initial supplies will be limited by a manufacturing changeover required by the FDA.

Click here to view the entire article.